Low
₹
High
₹
| Previous Close | ₹8.31 |
|---|---|
| Day's Range | ₹8.31 - ₹8.31 |
| Open | ₹8.31 |
| 52 Week Range | ₹03.57 - ₹10.94 |
| Volume | 50 |
| Market Cap | ₹0.00 |
| Trade Value ( ₹ in Lacs) | 0.00 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 396.72 |
| TTM EPS (₹) | 0.02 |
| P/E Ratio | 203.51 |
| Book Value(₹) | 0.61 |
| PAT Margin (%) | 6.06 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 0.37 |
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 3.95 | 3.95 |
| Expenses | N/A | N/A |
| PBT | 0.29 | 2.09 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 0.24 | 1.87 |
| Founded | 2011 |
|---|
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,68,458.16 | 1,950.00 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,93,383.24 | 7,301.75 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,69,828.54 | 4,994.80 | 3,421.30 - 3,421.30 |
| Apollo Hospitals Enterprise Ltd. | 1,28,455.06 | 8,920.00 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,16,164.12 | 1,439.30 | 1,165.70 - 1,165.70 |
| Zydus Lifesciences Ltd. | 1,15,151.84 | 1,158.25 | 835.50 - 835.50 |
| Lupin Ltd. | 1,13,933.79 | 2,509.20 | 1,836.80 - 1,836.80 |
| Max Healthcare Institute Ltd. | 1,07,293.66 | 1,104.00 | 903.00 - 903.00 |
| Mankind Pharma Ltd. | 1,05,173.56 | 2,547.15 | 1,909.70 - 1,909.70 |
| Dr. Reddy's Laboratories Ltd. | 1,02,648.43 | 1,231.40 | 1,148.40 - 1,148.40 |
No Records Found
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 124.55 | 24.21 | 414.46 | 124.55 | 24.21 | 414.46 | 363.20 | 190.46 | 90.70 |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.96 | 1.80 | 8.89 |
| PBIDT | 16.88 | 0.97 | 1640.21 | 16.88 | 0.97 | 1640.21 | 25.05 | 12.55 | 99.60 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | -100.00 |
| PBDT | 16.88 | 0.97 | 1640.21 | 16.88 | 0.97 | 1640.21 | 25.05 | 12.53 | 99.92 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBT | 16.88 | 0.97 | 1640.21 | 16.88 | 0.97 | 1640.21 | 25.05 | 12.53 | 99.92 |
| TAX | 4.36 | 0.25 | 1644.00 | 4.36 | 0.25 | 1644.00 | 6.90 | 2.37 | 191.14 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PAT | 12.52 | 0.72 | 1638.89 | 12.52 | 0.72 | 1638.89 | 18.15 | 10.16 | 78.64 |
| Equity | 146.35 | 146.35 | 0.00 | 146.35 | 146.35 | 0.00 | 146.35 | 146.35 | 0.00 |
| PBIDTM(%) | 13.55 | 4.01 | 238.26 | 13.55 | 4.01 | 238.26 | 6.90 | 6.59 | 4.67 |
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Artemis Medicare Service has informed that it enclosed the copy of the advertisement published in the newspapers, The Financial Express (English National Daily Newspaper- all editions) and The Jansatta (Hindi National Daily Newspaper- Delhi edition) on July 15, 2026, regarding the public notice for the opening of a Special Window for Transfer and Dematerialisation of Physical Securities.
The above information is a part of company’s filings submitted to BSE.
Further to letter dated May 07, 2026, intimating that the 48th Annual General Meeting (‘AGM’) of the Company will be held on Thursday August 06, 2026 at 3:30 PM (IST) through Video Conferencing (‘VC’) / Other Audio Visual Means (‘OAVM’) in compliance with applicable provisions of the Companies Act, 2013 (‘the Act’) and rules made thereunder, the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’) read with all applicable circulars on the matter issued by the Ministry of Corporate Affairs (‘MCA’) and the Securities and Exchange Board of India (‘SEBI’) and pursuant to the provisions of Regulation 30 and 34 of the SEBI Listing Regulations, Biocon has informed that it enclosed the Notice of 48th AGM and Integrated Annual Report (BRSR, GRI & ESG Data Book FY26 is a supplement to the Integrated Annual Report) of the Company for the Financial Year 2025-26. The same are also made available on the website of the Company at www.biocon.com. In compliance with the applicable Circulars issued by MCA and SEBI Listing Regulations, the Notice of the 48th AGM along with the Integrated Annual Report for the Financial Year 2025-26 are being sent only through electronic mode to those Members whose e-mail IDs are registered with the Registrar and Share Transfer Agents (‘RTA’) (in case of shares held in physical form) or with Depository Participants (‘DPs’) (in case of shares held in demat form). Further, pursuant to Regulation 36(1)(b) of SEBI Listing Regulations, the Company has also sent letter containing the weblink along with the path and QR Code to access the Notice of the 48th AGM and Integrated Annual Report of the Company for Financial Year 2025-2026, to those Members who have not registered their e-mail IDs with the RTA or with the DPs. Copy of the said letter is enclosed.
The above information is a part of company’s filings submitted to BSE.
No Records Found
The current share price of Looks Health Services Ltd. is ₹8.31 as of 2026-07-16.
The market capitalisation of Looks Health Services Ltd. is ₹9.12 as of 2026-07-15.
The 1-year return of Looks Health Services Ltd. is 0.00% as of 2025-07-15.
The P/E ratio of Looks Health Services Ltd. is 203.51 as of 2026-07-16.
The 52-week high and low of Looks Health Services Ltd. are ₹10.94 and ₹3.57, respectively, as of 2026-07-16.
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.